Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colonic Neoplasms 3Breast Neoplasms 3Rectal Neoplasms 2Leukemia, Myeloid, Acute 2Colorectal Neoplasms 2Vitamin D Deficiency 1Renal Insufficiency, Chronic 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Precancerous Conditions 1Osteoporosis 1Obesity 1Neurofibromatosis 1 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Musculoskeletal Diseases 1Melanoma 1Locally Advanced Breast Cancer and Large Operable Breast Cancer 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, B-Cell 1Leukemia 1Healthy, no Evidence of Disease 1Congenital Abnormalities 1Cardiovascular Diseases 1

Interventions

Epinephrine 1Clonidine 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Musculoskeletal Diseases × Cholecalciferol × Clear all
NCT01809171 2015-10-21

Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients

Universitaire Ziekenhuizen KU Leuven

Phase 2/3 Terminated
15 enrolled
Breast

Breast Neoplasms, Musculoskeletal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡